(Q28348712)

2

0 references

C Trautwein

3

0 references

H Wedemeyer

4

0 references

A Falorni

5

0 references

H Frank

6

0 references

A von zur Mühlen

7

0 references

M P Manns

8

0 references

G Brabant

Binding of hepatitis C virus to CD81

9

0 references

language of work or name

English

0 references

publication date

March 2001

0 references

published in

Gut

0 references

volume

48

0 references

issue

3

0 references

page(s)

378-83

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Association of diabetes mellitus and chronic hepatitis C virus infection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Side effects of high-dose interferon therapy for chronic hepatitis C.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

ICA512 Autoantibody Radioassay

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Induction of autoreactive B cells allows priming of autoreactive T cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Inhibition of B cell receptor-mediated apoptosis by IFN.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Thyroid function and autoimmunity in 215 patients seropositive for the hepatitis C virus

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Immunological disorders in C virus chronic active hepatitis: a prospective case-control study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Effect of interferon on glucose tolerance and insulin sensitivity.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Rapidly reversible increase in insulin requirement with interferon

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Longitudinal Study of Antibodies against Thyroid in Patients Undergoing Interferon-&alpha; Therapy for HCV Chronic Hepatitis

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760154

Interferon induces insulin resistance in patients with chronic active hepatitis C

27 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Exacerbation of type 2 diabetes mellitus during interferon-alfa therapy for chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Antibodies to glutamic acid decarboxylase induced by interferon-alpha therapy for chronic viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

GAD, a single autoantigen for diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Liver disease associated with anti-liver-kidney microsome antibody in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Induction of hyperthyroidism by interferon-alpha-2b

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Islet Cell and Thyrogastric Antibodies in 633 Consecutive 15- to 34-Yr-Old Patients in the Diabetes Incidence Study in Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Antibodies to GAD in chronic hepatitis C patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11171829

12 December 2020

Identifiers

DOI

10.1136/GUT.48.3.378

1 reference

release_2eh3i5l65fharjuqi67i4zqxju

Fatcat ID

0 references

1 reference

1 reference

PubMed publication ID

11171829

1 reference